Stocks Reaffirm To Gain Attentions: Ford Motor Company (NYSE:F), Hologic, Inc. (NASDAQ:HOLX)

Ford Motor Company (NYSE:F) [Trend Analysis] retains strong position in active trade, as shares scoring 3.79% to $12.59 in a active trade session, while looking at the shares volume, around 40.34 Million shares have changed hands in this session. Ford Motor Co. (F) reported that it is canceling plans for a new $1.6 billion plant in San Luis Potosi, Mexico, and investing $700 million in its Flat Rock, Mich., plant’s expansion, as part of a push into electric vehicles in the next five years.

The news came just hours after President-elect Donald Trump tweeted at Ford rival General Motors Co. (GM) saying the company needs to be taxed for certain versions of the Chevrolet Cruze small car that it imports from Mexico to U.S. dealers. Ford said it will add 700 jobs at the Michigan plant, which will build high-tech electric vehicles and self-driving cars, as well as the Mustang and Lincoln Continental.

The moves are part of a planned $4.5 billion investment in electric vehicles by 2020 as the company works to become an auto and mobility company. The firm has institutional ownership of 56.70%, while insider ownership included 0.31%. F attains analyst recommendation of 2.80 with week’s performance of -2.18%. Investors looking further ahead will note that the Price to next year’s EPS is -9.81%.

Shares of Hologic, Inc. (NASDAQ:HOLX) [Trend Analysis] swings enthusiastically in regular trading session, it a gain of 0.10% to close at $40.16. Hologic, Inc. (HOLX) declared that the U.S. Food and Drug Administration (FDA) have granted PMA approval for the Company’s HIV-1 viral load monitoring assay. The Aptima HIV-1 Quant assay is a nucleic acid amplification test for the quantitative detection of RNA from HIV in plasma specimens.

The Aptima HIV-1 Quant assay runs on Hologic’s Panther system, a market-leading, integrated platform that fully automates all aspects of testing, from sample to result. The system substantially reduces hands-on time for laboratories by providing random and continuous access with rapid turnaround time. Moving forward to saw long-term intention, the experts calculate Return on Investment of 8.40%. The stock is going forward its fifty-two week low with 26.13% and lagging behind from its 52-week high price with -2.07%. HOLX last month stock price volatility remained 1.77%.


About Aaron Smithies

Aaron Smithies has a wide look on current monetary and financial events. He is an editor and a writer. His views; At Streetwise Report, we think the best opportunities arise from a complete understanding of all investing disciplines in order to identify the most attractive stocks at any given time. Interests: Biotech, Finical markets, Dividend stock ideas & income, Energy stocks, Consumer goods stocks

Leave a Reply

Your email address will not be published. Required fields are marked *